Advances in RIPK1 kinase inhibitors (vol 13, 976435, 2022)

被引：0
|
作者：
Frontiers Prod Off [1 ]
机构：
[1] Frontiers Media SA, Lausanne, Switzerland
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 13卷
关键词：
inhibitor; receptor interacting protein 1 (RIP1); programmed necrosis; necrosis; RIP1 (RIPK1);
D O I：
10.3389/fphar.2022.1123234
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Contribution of RIPK1 kinase activity to cell death induced by anti-cancer agents using 7-CI-O-Nec-1, a potent and highly selective RIPK1 kinase inhibitor
    Alavi, Alireza
    Benetatos, Christopher
    Yuan, Junying
    Degterev, Alexei
    Franklin, Jessica
    Condon, Stephen
    McKinlay, Mark
    Chunduru, Srinivas
    CANCER RESEARCH, 2009, 69
  • [42] Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors
    Niu, Ao
    Lin, Lizhi
    Zhang, Danyang
    Jiang, Kaixuan
    Weng, Dan
    Zhou, Wenjia
    Wang, Jinxin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 59
  • [43] Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus
    Peng, Lin
    Wang, Pengcheng
    Xu, Xiaodong
    Chen, Dacheng
    Xu, Feng
    Yang, Fan
    Yang, Shuying
    Xia, Hongguang
    Liu, Zhi-Hong
    Qin, Weisong
    LUPUS SCIENCE & MEDICINE, 2024, 11 (01):
  • [44] Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis
    Van, Trieu-My
    Polykratis, Apostolos
    Straub, Beate Katharina
    Kondylis, Vangelis
    Papadopoulou, Nikoletta
    Pasparakis, Manolis
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07): : 2662 - 2677
  • [45] Understanding the role of RIPK1 kinase activity in atherogenesis: a genetic versus pharmacological approach
    Puylaert, P.
    Coornaert, I
    Neutel, C. H. G.
    Bertrand, M. J. M.
    Guns, P. J.
    De Meyer, G. R. Y.
    Martinet, W.
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [46] Questioning the RIPK1 kinase activity involvement in acetaminophen-induced hepatotoxicity in mouse
    Hameed, Huma
    Farooq, Muhammad
    Piquet-Pellorce, Claire
    Hamon, Annaig
    Samson, Michel
    Le Seyec, Jacques
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 178 : 243 - 245
  • [47] Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors
    Hao, Yanan
    Shao, Hongming
    Qu, Zhuo
    Li, Jiao
    Shi, Ying
    Zhang, Wannian
    Yu, Jianqiang
    Fu, Peng
    Zhuang, Chunlin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [48] RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD
    Van Eeckhoutte, Hannelore P.
    Donovan, Chantal
    Kim, Richard Y.
    Conlon, Thomas M.
    Ansari, Meshal
    Khan, Haroon
    Jayaraman, Ranjith
    Hansbro, Nicole G.
    Dondelinger, Yves
    Delanghe, Tom
    Beal, Allison M.
    Geddes, Brad
    Bertin, John
    Vanden Berghe, Tom
    De Volder, Joyceline
    Maes, Tania
    Vandenabeele, Peter
    Vanaudenaerde, Bart M.
    Deforce, Dieter
    Skevin, Sonja
    Van Nieuwerburgh, Filip
    Verhamme, Fien M.
    Joos, Guy F.
    Idrees, Sobia
    Schiller, Herbert B.
    Yildirim, Ali Oender
    Faiz, Alen
    Bertrand', Mathieu J. M.
    Brusselle, Guy G.
    Hansbro, Philip M.
    Bracke, Ken R.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
  • [49] ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis
    Koerner, Lioba
    Wachsmuth, Laurens
    Kumari, Snehlata
    Schwarzer, Robin
    Wagner, Theresa
    Jiao, Huipeng
    Pasparakis, Manolis
    CELL DEATH AND DIFFERENTIATION, 2024, 31 (07): : 938 - 953
  • [50] Receptor Interacting Protein Kinase 1 (RIPK1) in Hepatocytes Does Not Mediate Murine Acetaminophen Toxicity
    Schneider, Anne T.
    Gautheron, Jeremie
    Tacke, Frank
    Vucur, Mihael
    Luedde, Tom
    HEPATOLOGY, 2016, 64 (01) : 306 - 308
12345